{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:04:31Z","timestamp":1790186671107,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006108","name":"NIH National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["1KL2TR001411"],"award-info":[{"award-number":["1KL2TR001411"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boston University School of Medicine Department of Medicine Career Investment Award"},{"DOI":"10.13039\/100006108","name":"NIH National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["1KL2TR001411"],"award-info":[{"award-number":["1KL2TR001411"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Boston University School of Medicine Department of Medicine Career Investment Award"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The use of hydrocortisone in adult patients with septic shock is controversial, and the effectiveness of adding fludrocortisone to hydrocortisone remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess the comparative effectiveness and safety of fludrocortisone plus hydrocortisone, hydrocortisone alone, and placebo or usual care in adults with septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and a Bayesian network meta-analysis of peer-reviewed randomized trials were conducted. The primary outcome was all-cause mortality at last follow-up. Treatment effects are presented as relative risks (RRs) with 95% credible intervals (CrIs). Placebo or usual care was the reference treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Among 7,553 references, we included 17 trials (7,688 patients). All-cause mortality at last follow-up was lowest with fludrocortisone plus hydrocortisone (RR, 0.85; 95% CrI, 0.72\u20130.99; 98.3% probability of superiority, moderate-certainty evidence), followed by hydrocortisone alone (RR, 0.97; 95% CrI, 0.87\u20131.07; 73.1% probability of superiority, low-certainty evidence). The comparison of fludrocortisone plus hydrocortisone versus hydrocortisone alone was based primarily on indirect evidence (only two trials with direct evidence). Fludrocortisone plus hydrocortisone was associated with a 12% lower risk of all-cause mortality compared with hydrocortisone alone (RR, 0.88; 95% CrI, 0.74\u20131.03; 94.2% probability of superiority, moderate-certainty evidence).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In adult patients with septic shock, fludrocortisone plus hydrocortisone was associated with lower risk of all-cause mortality at last follow-up than placebo and hydrocortisone alone. The scarcity of head-to-head trials comparing fludrocortisone plus hydrocortisone versus hydrocortisone alone led our network meta-analysis to rely primarily on indirect evidence for this comparison. Although we undertook several sensitivity analyses and assessments, these findings should be considered while also acknowledging the heterogeneity of included trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202310-1785oc","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T13:58:52Z","timestamp":1706191132000},"page":"1219-1228","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":50,"title":["Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1093","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4978-6353","authenticated-orcid":false,"given":"Bijan","family":"Teja","sequence":"first","affiliation":[{"name":"Interdepartmental Division of Critical Care Medicine and"},{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesia, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Berube","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8574-832X","authenticated-orcid":false,"given":"Tiago V.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-0316","authenticated-orcid":false,"given":"Anica C.","family":"Law","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-541X","authenticated-orcid":false,"given":"Carly","family":"Schanock","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin Libraries, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Pang","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5477-8422","authenticated-orcid":false,"given":"Hannah","family":"Wunsch","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesiology, Weill Cornell Medicine, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4685-6894","authenticated-orcid":false,"given":"Allan J.","family":"Walkey","sequence":"additional","affiliation":[{"name":"Division of Health Systems Sciences, Medical School, University of Massachusetts, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7161-5254","authenticated-orcid":false,"given":"Nicholas A.","family":"Bosch","sequence":"additional","affiliation":[{"name":"The Pulmonary Center, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"2026012204235831700_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2026012204235831700_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"2026012204235831700_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(10)60446-1","article-title":"Critical care and the global burden of critical illness in adults","volume":"376","author":"Adhikari","year":"2010","journal-title":"Lancet"},{"key":"2026012204235831700_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"2026012204235831700_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jemermed.2017.05.024","article-title":"Controversies in corticosteroid use for sepsis","volume":"53","author":"Long","year":"2017","journal-title":"J Emerg Med"},{"key":"2026012204235831700_bib6","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012204235831700_bib7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib8","doi-asserted-by":"crossref","first-page":"EVIDoa2300034","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"key":"2026012204235831700_bib9","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1164\/ajrccm.153.5.8630621","article-title":"Muscle weakness in mechanically ventilated patients with severe asthma","volume":"153","author":"Leatherman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204235831700_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Med"},{"key":"2026012204235831700_bib11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"2026012204235831700_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"2026012204235831700_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012204235831700_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s42077-022-00259-6","article-title":"Evaluation of the role of hydrocortisone either alone or combined with fludrocortisone in the outcome of septic shock in adults","volume":"14","author":"Labib","year":"2022","journal-title":"Ain-Shams Journal of Anesthesiology"},{"key":"2026012204235831700_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijid.2022.10.021","article-title":"Effect of corticosteroids in patients with COVID-19: a Bayesian network meta-analysis","volume":"125","author":"Wang","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2026012204235831700_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40256-023-00586-5","article-title":"Bayesian network meta-analysis of randomized controlled trials on the efficacy of antiarrhythmics in the pharmacological cardioversion of paroxysmal atrial fibrillation","volume":"23","author":"Orso","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"key":"2026012204235831700_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026012204235831700_bib18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/rccm.202005-1829OC","article-title":"Use of hydrocortisone, ascorbic acid, and thiamine in adults with septic shock","volume":"202","author":"Vail","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204235831700_bib19","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"2026012204235831700_bib20","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026012204235831700_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Ann Intern Med"},{"key":"2026012204235831700_bib22","doi-asserted-by":"crossref","first-page":"e074495","DOI":"10.1136\/bmj-2022-074495","article-title":"A guide and pragmatic considerations for applying GRADE to network meta-analysis","volume":"381","author":"Izcovich","year":"2023","journal-title":"BMJ"},{"key":"2026012204235831700_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/eb-2017-102753","article-title":"Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article","volume":"20","author":"Chaimani","year":"2017","journal-title":"Evid Based Ment Health"},{"key":"2026012204235831700_bib24","volume-title":"NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials","author":"Dias","year":"2014"},{"key":"2026012204235831700_bib25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1164\/rccm.202108-1972OC","article-title":"Association of positive end-expiratory pressure and lung recruitment selection strategies with mortality in acute respiratory distress syndrome: a systematic review and network meta-analysis","volume":"205","author":"Dianti","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204235831700_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2026012204235831700_bib27","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1001\/jama.2012.13444","article-title":"Empirical evaluation of very large treatment effects of medical interventions","volume":"308","author":"Pereira","year":"2012","journal-title":"JAMA"},{"key":"2026012204235831700_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ije\/dys041","article-title":"Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews","volume":"41","author":"Turner","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2026012204235831700_bib29","volume-title":"Bayesian approaches to clinical trials and health-care evaluation","author":"Spiegelhalter","year":"2004"},{"key":"2026012204235831700_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"van Valkenhoef","year":"2016","journal-title":"Res Synth Methods"},{"key":"2026012204235831700_bib31","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"2026012204235831700_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2026012204235831700_bib33","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in Stata","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"2026012204235831700_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock. 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v095.i07","article-title":"MultiBUGS: a parallel implementation of the BUGS modelling framework for faster Bayesian inference","volume":"95","author":"Goudie","year":"2020","journal-title":"J Stat Softw"},{"key":"2026012204235831700_bib37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0b013e31816f48f2","article-title":"Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach","volume":"36","author":"Aboab","year":"2008","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial","volume":"182","author":"Arabi","year":"2010","journal-title":"CMAJ"},{"key":"2026012204235831700_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study","volume":"27","author":"Briegel","year":"1999","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial","volume":"42","author":"Gordon","year":"2014","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"2026012204235831700_bib43","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","article-title":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial","volume":"35","author":"Lv","year":"2017","journal-title":"Am J Emerg Med"},{"key":"2026012204235831700_bib44","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.CCM.0000186370.78639.23","article-title":"Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock","volume":"33","author":"Oppert","year":"2005","journal-title":"Crit Care Med"},{"key":"2026012204235831700_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"2026012204235831700_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15171\/jept.2017.25","article-title":"The effect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: a randomized control trial","volume":"4","author":"Talebi Doluee","year":"2018","journal-title":"Journal of Emergency Practice and Trauma"},{"key":"2026012204235831700_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit Care"},{"key":"2026012204235831700_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012204235831700_bib49","first-page":"529","article-title":"The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock [in Chinese]","volume":"21","author":"Hu","year":"2009","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2026012204235831700_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bja.2020.04.092","article-title":"Theory and practical use of Bayesian methods in interpreting clinical trial data: a narrative review","volume":"125","author":"Ferreira","year":"2020","journal-title":"Br J Anaesth"},{"key":"2026012204235831700_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bmjebm-2022-111928","article-title":"Theory and practice of Bayesian and frequentist frameworks for network meta-analysis","volume":"28","author":"Sadeghirad","year":"2023","journal-title":"BMJ Evid Based Med"},{"key":"2026012204235831700_bib52","first-page":"1549","article-title":"Characterization of the human mineralocorticoid receptor gene 5\u2032-regulatory region: evidence for differential hormonal regulation of two alternative promoters via nonclassical mechanisms","volume":"10","author":"Zennaro","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2026012204235831700_bib53","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"key":"2026012204235831700_bib54","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.4049\/jimmunol.139.7.2303","article-title":"Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids","volume":"139","author":"Bochner","year":"1987","journal-title":"J Immunol"},{"key":"2026012204235831700_bib55","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice","volume":"120","author":"Usher","year":"2010","journal-title":"J Clin Invest"},{"key":"2026012204235831700_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/019021401750069384","article-title":"Modulation of transalveolar fluid absorption by endogenous aldosterone in adult rats","volume":"27","author":"Suzuki","year":"2001","journal-title":"Exp Lung Res"},{"key":"2026012204235831700_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials: an overview of theory and example reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204235831700_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/anae.15263","article-title":"False individual patient data and zombie randomised controlled trials submitted to Anaesthesia","volume":"76","author":"Carlisle","year":"2021","journal-title":"Anaesthesia"},{"key":"2026012204235831700_bib59","doi-asserted-by":"crossref","first-page":"e019918","DOI":"10.1161\/JAHA.120.019918","article-title":"Sodium-glucose cotransporter 2 inhibitors, all-cause mortality, and cardiovascular outcomes in adults with type 2 diabetes: a Bayesian meta-analysis and meta-regression","volume":"10","author":"Odutayo","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026012204235831700_bib60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","article-title":"Bayes factors","volume":"90","author":"Kass","year":"1995","journal-title":"J Am Stat Assoc"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/209\/10\/1219\/66426090\/ajrccm_209_10_1219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/209\/10\/1219\/66426090\/ajrccm_209_10_1219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:24:25Z","timestamp":1769073865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/209\/10\/1219\/8426936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5,15]]},"published-print":{"date-parts":[[2024,5,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202310-1785oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"2023-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}